Literature DB >> 33909642

Reliability of heart rate and respiration rate measurements with a wireless accelerometer in postbariatric recovery.

Fleur Jacobs1, Jai Scheerhoorn2, Eveline Mestrom3, Jonna van der Stam4,5, R Arthur Bouwman3,6, Simon Nienhuijs2.   

Abstract

Recognition of early signs of deterioration in postoperative course could be improved by continuous monitoring of vital parameters. Wearable sensors could enable this by wireless transmission of vital signs. A novel accelerometer-based device, called Healthdot, has been designed to be worn on the skin to measure the two key vital parameters respiration rate (RespR) and heart rate (HeartR). The goal of this study is to assess the reliability of heart rate and respiration rate measured by the Healthdot in comparison to the gold standard, the bedside patient monitor, during the postoperative period in bariatric patients. Data were collected in a consecutive group of 30 patients who agreed to wear the device after their primary bariatric procedure. Directly after surgery, a Healthdot was attached on the patients' left lower rib. Vital signs measured by the accelerometer based Healthdot were compared to vital signs collected with the gold standard patient monitor for the period that the patient stayed at the post-anesthesia care unit. Over all patients, a total of 22 hours of vital signs obtained by the Healthdot were recorded simultaneously with the bedside patient monitor data. 87.5% of the data met the pre-defined bias of 5 beats per minute for HeartR and 92.3% of the data met the pre-defined bias of 5 respirations per minute for RespR. The Healthdot can be used to accurately derive heart rate and respiration rate in postbariatric patients. Wireless continuous monitoring of key vital signs has the potential to contribute to earlier recognition of complications in postoperative patients. Future studies should focus on the ability to detect patient deterioration in low-care environments and at home after discharge from the hospital.

Entities:  

Year:  2021        PMID: 33909642     DOI: 10.1371/journal.pone.0247903

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  2 in total

1.  Noninvasive measurement of the vital signs of cancer patients with a dual-path microbend fiber sensor.

Authors:  Ying Wang; Meizheng You; Yanhong Zhang; Sumei Wu; Yi Zhang; Huicheng Yang; Ting Zheng; Xiaohui Chen; Zhihao Chen; Xianhe Xie; Xiaochun Zheng
Journal:  Biomed Opt Express       Date:  2022-01-26       Impact factor: 3.732

2.  Postbariatric EArly discharge Controlled by Healthdot (PEACH) trial: study protocol for a preference-based randomized trial.

Authors:  Jai Scheerhoorn; Lisa van Ede; Misha D P Luyer; Marc P Buise; R Arthur Bouwman; Simon W Nienhuijs
Journal:  Trials       Date:  2022-01-21       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.